Nano Particle Guidelines

Embed Size (px)

Citation preview

  • 8/12/2019 Nano Particle Guidelines

    1/3

    Nanoparticle Handling Guidelines

    Background

    Nanoparticles are ultrafine particles measuring between 1-100 nanometers (nm) in one

    dimension. In addition to the novel size of nanoparticles or structures, uses are also derivedfrom the composition of the nanoparticles, which can be chemical or biological. oncerns withsafet! regarding the use of nanotechnolog! have arisen primaril! from the recognition of severaluni"ue attributes of nanoparticles#

    $he ultra-small particle size permits the particles to be carried deepl! into tissues.

    %articles ma! be deepl! respired into the lungs, ma! pass through the blood-brainbarrier& or translocate between organs.

    $he molecular structure of nanoparticles and the relativel! greater surface area confer

    on these particles different chemical and biological reactivities than larger structuresmade from the same elements or molecules.

    'lthough insufficient information eists to predict the heath hazard posed b! the eposure tonanoparticles, and such effects will var! depending on the composition of the nanoparticles,current research indicates that eposure via inhalation and sin contact can result in theseparticles entering the bod!. *esults from human and animal studies show inhaled nanoparticlescan deposit in the respirator! tract. 'nimal studies also show nanoparticles can enter thebloodstream and translocate to other organs. Nanoparticles have the greatest potential to enterthe bod! if the! become airborne or come into contact with the sin, e!es or mucousmembranes. +ome evidence suggests that nanoparticles ma! be more toic to tissues thanlarger molecular structures. posure to nanoparticles carr!ing genetic material ma! result ingenetic or immunologic effects. posure to nanoparticles carr!ing infectious agents ma!cause infectious diseases.

    NI+, the NI, and the %' promote the incorporation of cautionar! measures in research tominimize or eliminate eposures to nanoparticles. 'ccording to NI+, the following worplacetass ma! increase the ris of eposure to nanoparticles#

    $ /oring with nanoparticles in li"uid media without ade"uate protection (e.g., gloves, safet!

    glasses) will increase the ris of sin or e!e eposure.$ /oring with nanoparticles in li"uid media during pouring or miing operations, or where a

    high degree of agitation is involved, will lead to an increased lielihood of inhalation ofrespirable droplets which ma! be formed.

    $ enerating nanoparticles in the gas phase in non-enclosed s!stems will increase the

    chances of aerosol release to the worplace.

    $ andling nano-structured powders will lead to the possibilit! of aerosolization.

    Control Procedures

    /hile the health riss from eposure to nanoparticles are not well nown and will var!depending on the composition of the particles, wor practices and engineering controlprocedures to prevent eposure are well understood. $he following are minimum engineering,wor practice and ventilation controls re"uired when handling nanoparticles to reduce potentialeposure#

    1

  • 8/12/2019 Nano Particle Guidelines

    2/3

    $ ab coats must be worn. ab coats must be laundered using 2niversit! provided lab coat

    laundr! services. ab coats ma! not be taen to private homes and laundered.$ loves must be worn when handling nanomaterials. 3ecause sin penetration is a concern,

    gloves must cover the wrist and an! sin on the arm eposed b! the lab coat.$ 'rm sleeves are re"uired where high levels of eposure or splashes of solutions containing

    nanoparticles are anticipated.$ +tandard safet! glasses should be worn.

    $ /henever possible, wor should be performed in a chemical fume hood or biological safet!

    cabinet. /hen wor with nanoparticles must be performed outside a hood or cabinet, safet!goggles instead of safet! glasses should be worn to prevent e!e eposure. *espiratorsma! be re"uired for activities that cannot be controlled using ventilation.

    o 4r! nano-materials must be handled in a fume hood or biological safet! cabinet.

    /or on the open bench with dr! nanoparticles is not allowed.o 'erosol producing activities (such as sonication, vorteing and centrifuging) ma! not

    be conducted on the open bench.o 'ctivities that are liel! to release nanoparticles (such as the opening and empt!ing

    of tubes, weighing of dr! nano particles) shall not be performed on the open bench.

    o +olutions containing nanoparticles should be handled over disposable bench covers.$ $ransport of dr! nanoparticles should occur in closed containers.

    $ and washing facilities must be provided in all labs. and washing must be performed after

    handling nano-materials.$ 3ench tops and other surfaces should be cleaned after each wor activit! using a cleaning

    solution suitable for the t!pe of nanoparticles being used.$ 'dministration of nanoparticles using needles5s!ringes should be done using a safe needle

    device whenever available. +uch devices minimize the potential for a needlestic either b!having a sliding sheath or guard that covers needle after use or having a retraction featurewhich isolates the needle inside the s!ringe. nl! needle-locing s!ringes or disposables!ringe-needle units (i.e., needle is integral to the s!ringe) ma! be used for the in6ection ofnanoparticles containing recombinant 4N' molecules.

    OUHSC Committee Approvals

    %rotocols involving the administration of nanoparticles to animals re"uires Institutional 'nimalare and 2se ommittee (I'2) approval. 4epending on the composition of thenanoparticles, +ection 7 (for nanoparticles carr!ing genetic material) or +ection N (for all othernanoparticles) must be completed on the I'2 form. +tandard perating %rocedures (+%s)for the preparation and administration of the nanoparticles must be developed and submitted inthe appropriate section of the form.

    %rotocols involving the administration of nanoparticles containing genetic material to eitheranimals or humans re"uires Institutional 3iosafet! ommittee (I3) approval. +%s for the

    preparation and administration of the nanoparticles must be developed and submitted with theprotocol.

    %rotocols involving the administration of nanoparticles to humans re"uires Institutional *eview3oard (I*3)approval.

    $he guidelines given in this document are minimum precautions. 3ecause the composition anduse of nanoparticles will var! from pro6ect to pro6ect, additional precautions or procedures ma!

    8

    http://www.ouhsc.edu/IACUC/http://www.ouhsc.edu/IACUC/http://www.ouhsc.edu/ibc/default.asphttp://www.ouhsc.edu/irb/http://www.ouhsc.edu/irb/http://www.ouhsc.edu/IACUC/http://www.ouhsc.edu/IACUC/http://www.ouhsc.edu/ibc/default.asphttp://www.ouhsc.edu/irb/http://www.ouhsc.edu/irb/
  • 8/12/2019 Nano Particle Guidelines

    3/3

    be imposed b! these ommittees based on the review of the proposal and potential rissidentified for that pro6ect.

    9